Earnings summaries and quarterly performance for Delek US Holdings.
Executive leadership at Delek US Holdings.
Avigal Soreq
Chief Executive Officer and President
Denise McWatters
Executive Vice President, General Counsel, and Corporate Secretary
Joseph Israel
Executive Vice President, President, Refining and Renewables
Mark Hobbs
Executive Vice President and Chief Financial Officer
Reuven Spiegel
Executive Vice President, Special Projects
Robert Wright
Executive Vice President
Board of directors at Delek US Holdings.
Christine Benson Schwartzstein
Director
Ezra Uzi Yemin
Chairman of the Board
Gary M. Sullivan, Jr.
Director
Laurie Z. Tolson
Director
Leonardo Moreno
Director
Richard J. Marcogliese
Director
Shlomo Zohar
Director
Vasiliki (Vicky) Sutil
Director
William J. Finnerty
Lead Independent Director
Research analysts who have asked questions during Delek US Holdings earnings calls.
Jason Gabelman
TD Cowen
8 questions for DK
Matthew Blair
Tudor, Pickering, Holt & Co.
8 questions for DK
Alexa Petrick
Goldman Sachs
5 questions for DK
Jean Ann Salisbury
Bank of America
5 questions for DK
Joe Laetsch
Morgan Stanley
5 questions for DK
Keith Stanley
Wolfe Research, LLC
5 questions for DK
Manav Gupta
UBS Group
3 questions for DK
Joseph Laetsch
Morgan Stanley
2 questions for DK
Alexia Patrick
BofA Securities
1 question for DK
Douglas George Blyth Leggate
Wolfe Research
1 question for DK
Doug Leggate
Wolfe Research
1 question for DK
John Royall
JPMorgan Chase & Co.
1 question for DK
Michail Paraskevopoulos
Citigroup Inc.
1 question for DK
Neil Mehta
Goldman Sachs
1 question for DK
Roger Read
Wells Fargo & Company
1 question for DK
Ryan Todd
Simmons Energy
1 question for DK
Recent press releases and 8-K filings for DK.
- Delek US Holdings, Inc. (DK) filed an 8-K on January 12, 2026, to furnish an Investor Presentation that senior management will use for investor presentations starting the same day.
- The Enterprise Optimization Plan (EOP) is projected to increase annual cash flow by at least $180 million, and Delek Logistics Partners (DKL) distributions are expected to add over $150 million to free cash flow.
- An Inventory Intermediation Agreement (IIA) Revamp is anticipated to generate an additional $30 - $50 million in incremental free cash flow.
- The company provided 2026 guidance including Standalone M&R Capex of $200 - $220 million, which incorporates a BSR Turnaround in Q1 2026.
- Delek US reported adjusted EPS of $1.52 and adjusted EBITDA of approximately $319 million for Q3 2025, excluding SREs. Including SREs, adjusted EBITDA was $760 million and adjusted net income was $434 million or $7.13 per share.
- The company increased its Enterprise Optimization Plan (EOP) guidance to at least $180 million on an annual run rate basis, up from a previous midpoint of $150 million.
- Delek US expects to receive approximately $400 million in profits from the monetization of granted Small Refinery Exemption (SRE) RINs over the next six to nine months, following EPA approval of 2019-2024 SRE petitions.
- Delek Logistics (DKL) full-year 2025 EBITDA guidance was increased to between $500 million and $520 million.
- During Q3 2025, the company returned capital to shareholders through approximately $15 million in dividends and $15 million in share repurchases.
- Delek US Holdings reported adjusted EPS of $1.52 and adjusted EBITDA of approximately $319 million for Q3 2025, excluding SREs. Including SREs, adjusted EBITDA was approximately $760 million.
- The company increased its Enterprise Optimization Plan (EOP) annual run rate guidance to at least $180 million, with $60 million contributed in Q3 2025.
- EPA approval of pending Small Refinery Exemption (SRE) petitions is expected to generate approximately $400 million in profits from RIN monetization over the next six to nine months. Delek anticipates 100% of its refining capacity will qualify for SREs in 2025.
- Delek Logistics (DKL) full-year 2025 EBITDA guidance was raised to between $500 million and $520 million.
- In Q3 2025, Delek returned capital to shareholders through approximately $15 million in dividends and $15 million in share repurchases.
- Delek US Holdings reported Q3 2025 adjusted EPS of $1.52 and adjusted EBITDA of approximately $319 million, both excluding SREs. Including SREs, adjusted EBITDA was approximately $760 million.
- The company expects to receive approximately $400 million in profits from the monetization of granted RINs for 2023 and 2024 SRE petitions over the next six to nine months.
- Delek has again increased its Enterprise Optimization Plan (EOP) guidance to at least $180 million on an annual run rate basis, with approximately $60 million contributed in Q3.
- Delek Logistics (DKL) full-year 2025 EBITDA guidance has been increased to between $500 million and $520 million.
- During Q3, Delek paid approximately $15 million in dividends and bought back approximately $15 million of its shares.
- Delek US Holdings reported adjusted net income of $434.2 million or $7.13 per share and adjusted EBITDA of $759.6 million for the third quarter of 2025.
- These results include a $280.8 million benefit related to Small Refinery Exemptions (SREs), with ~$400 million in proceeds from historical SRE grants expected over the next six to nine months.
- The company increased its Enterprise Optimization Plan (EOP) annual run-rate cash flow improvements guidance to at least $180 million, recognizing ~$60 million in improvements during Q3 2025.
- Delek Logistics (DKL) raised its expected full-year adjusted EBITDA guidance range to $500-$520 million, and Delek US purchased ~$15 million in common stock during the quarter.
Quarterly earnings call transcripts for Delek US Holdings.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more